Acrivon Therapeutics, Inc.
ACRVCIK 0001781174 · Every Form 4 filed by insiders at this issuer.
Filings
10
Latest Mar 6, 2024
Unique insiders
9
Showing
10 of 10
Page 1
Top insiders
Most active reporters at Acrivon Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Miller Mary | Officer | 2 |
| Blume-Jensen Peter | OfficerDirector | 1 |
| Cuillerot Jean-Marie | Officer | 1 |
| Devroe Eric | Officer | 1 |
| Gamelin Erick | Officer | 1 |
| Holm-Jorgensen Rasmus | Officer | 1 |
| Magovcevic-Liebisch Ivana | Director | 1 |
| Masson Kristina | OfficerDirector | 1 |
| Palani Santhosh | Director | 1 |
All filings
10 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 6, 2024 | Palani Santhosh Director | Holdings only | — | — | — | |
| Feb 16, 2024 | Blume-Jensen Peter President and CEO · Director | F | 41,861 | $3.40 | $142,327 | |
| Feb 16, 2024 | Devroe Eric Chief Operating Officer | F | 723 | $3.40 | $2,458 | |
| Feb 16, 2024 | Gamelin Erick Chief Development Officer | F | 468 | $3.40 | $1,591 | |
| Feb 16, 2024 | Holm-Jorgensen Rasmus Chief Financial Officer | F | 434 | $3.40 | $1,476 | |
| Feb 16, 2024 | Masson Kristina EVP - Business Operations · Director | F | 579 | $3.40 | $1,969 | |
| Feb 16, 2024 | Miller Mary Chief Legal Officer | F | 217 | $3.40 | $738 | |
| Feb 9, 2024 | Magovcevic-Liebisch Ivana Director | Holdings only | — | — | — | |
| Jan 19, 2024 | Miller Mary Chief Legal Officer | F | 652 | $4.35 | $2,836 | |
| Jan 16, 2024 | Cuillerot Jean-Marie Chief Medical Officer | Holdings only | — | — | — |
Showing 1–10 of 10
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.